Form 4 for WST West Pharmaceutical Services
Accepted 2025-05-08 00:00:00 ET · period of report 2025-05-06 · accession 0001127602-25-013716 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-08 | 2025-05-06 | WST | FRIEL ROBERT F | Dir | A - Grant | $0.00 | +1,071 | 4,682 | +30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-06 | A | A | 1,071 | $0.00 | 4,681.98 | D | — | — | (F1) These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. |